Bioasis Technologies Statistics
Important Dates
The last earnings date was Friday, June 13, 2025.
| Earnings Date | Jun 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BIOAF has 79.41 million shares outstanding.
| Current Share Class | 79.41M |
| Shares Outstanding | 79.41M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.11
| Current Ratio | 0.11 |
| Quick Ratio | 0.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.25 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -80.58% |
| Return on Invested Capital (ROIC) | -677.89% |
| Return on Capital Employed (ROCE) | 167.02% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.98% in the last 52 weeks. The beta is 34.05, so BIOAF's price volatility has been higher than the market average.
| Beta (5Y) | 34.05 |
| 52-Week Price Change | -99.98% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 41.26 |
| Average Volume (20 Days) | 14,204 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BIOAF had revenue of 199,006 and -2.12 million in losses. Loss per share was -0.03.
| Revenue | 199,006 |
| Gross Profit | -516,746 |
| Operating Income | -2.27M |
| Pretax Income | -2.12M |
| Net Income | -2.12M |
| EBITDA | -2.20M |
| EBIT | -2.27M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 115,628 in cash and 1.64 million in debt, giving a net cash position of -1.52 million or -0.02 per share.
| Cash & Cash Equivalents | 115,628 |
| Total Debt | 1.64M |
| Net Cash | -1.52M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | -1.99M |
| Book Value Per Share | -0.03 |
| Working Capital | -2.38M |
Cash Flow
| Operating Cash Flow | -1.43M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | -259.66% |
| Operating Margin | -1,141.16% |
| Pretax Margin | -1,067.59% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BIOAF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.11% |
| Shareholder Yield | n/a |
| Earnings Yield | -2,689,327.85% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BIOAF has an Altman Z-Score of -39.78 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -39.78 |
| Piotroski F-Score | 4 |